The recalled items include three lots of the Ventolin HFA 200D inhalers. They are manufactured at GSK’s Zebulon, North Carolina, plant. Customers complained about a bulge in the inhaler wrapper that may indicate a leak of the propellant that administers the medicine.
“We currently don't anticipate a supply impact to Ventolin HFA 200D inhaler as a result of this issue,” GSK said in a statement.
The company said the defect does not pose a danger to patients.